Friday, September 27, 2019 7:04:50 PM
Under the tax code, investors can write off any amount of losses against their gains. Thus, if you lose $50,000 on one stock and make $50,000 on another, these gains and losses will offset each other. You won't owe any taxes on your $50,000 in gains because of your equally sized losses.
If your losses exceed your gains, you can write off up to $3,000 of the excess losses each year against your income. Thus, suppose you lose $53,000 on one stock and gain $50,000 on another. The gains and losses cancel out up to $50,000. The remaining $3,000 can be written off against your ordinary income during the year.
If your losses exceed your gains by more than $3,000, you'll have to carry your losses forward to future tax years. Thus, it's possible that if you take a very large tax loss in one year, you'll be able to write off a portion of your losses for years and years to come.
Maximizing your tax losses
The tax code is written such that short- and long-term capital gains and losses must first offset losses of the same type. Thus, short-term losses should offset short-term gains, and long-term losses would offset long-term gains.
However, if your losses from one type exceed the gains of the same kind, you can apply the excess to another type of gain. Thus, if you only had a short-term gain of $5,000 and a short-term loss of $10,000, you could apply the extra $5,000 of short-term losses to long-term gains.
If your losses exceed your gains, you can write off up to $3,000 of the excess losses each year against your income. Thus, suppose you lose $53,000 on one stock and gain $50,000 on another. The gains and losses cancel out up to $50,000. The remaining $3,000 can be written off against your ordinary income during the year.
If your losses exceed your gains by more than $3,000, you'll have to carry your losses forward to future tax years. Thus, it's possible that if you take a very large tax loss in one year, you'll be able to write off a portion of your losses for years and years to come.
Maximizing your tax losses
The tax code is written such that short- and long-term capital gains and losses must first offset losses of the same type. Thus, short-term losses should offset short-term gains, and long-term losses would offset long-term gains.
However, if your losses from one type exceed the gains of the same kind, you can apply the excess to another type of gain. Thus, if you only had a short-term gain of $5,000 and a short-term loss of $10,000, you could apply the extra $5,000 of short-term losses to long-term gains.
Recent MAJI News
- Form 253G2 - • Edgar (US Regulatory) • 05/26/2026 06:00:08 PM
- NexTel Medical Corp Enters Final Stage for Commercial Launch; Sets Sights on Revenue Generation and OTCQB Uplist • GlobeNewswire Inc. • 05/11/2026 03:53:17 PM
- NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test • GlobeNewswire Inc. • 04/07/2026 02:30:00 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/30/2026 04:15:02 AM
- Form 253G1 - • Edgar (US Regulatory) • 03/27/2026 07:12:08 PM
- Form 1-A POS - • Edgar (US Regulatory) • 03/26/2026 08:25:15 PM
- Form 1-A POS - • Edgar (US Regulatory) • 03/20/2026 08:23:33 PM
- Exousia Pro, Inc. Announces Favorable Litigation Settlement, Highlighting Significant Debt Elimination and Share Cancellation to Enhance Shareholder Value • GlobeNewswire Inc. • 03/16/2026 02:15:00 PM
- Form 1-A POS - • Edgar (US Regulatory) • 03/11/2026 07:11:39 PM
- Exousia Pro, Inc. Announces Strategic Elimination of Future Dilutive Issuance of 47 Million Shares, Progresses Toward Definitive Agreements for Telehealth Acquisitions • GlobeNewswire Inc. • 03/05/2026 06:00:20 PM
- Form 1-A POS - • Edgar (US Regulatory) • 02/19/2026 09:39:04 PM
- Form 253G2 - • Edgar (US Regulatory) • 02/11/2026 08:06:08 PM
- Exousia Pro, Inc. Accelerates Strategic Expansion with Third Telehealth Acquisition; Strengthens Pathway to Low-Cost Customer Acquisition • GlobeNewswire Inc. • 02/10/2026 03:30:00 PM
- Form 253G2 - • Edgar (US Regulatory) • 01/15/2026 06:47:01 PM
- Form 253G1 - • Edgar (US Regulatory) • 01/14/2026 09:54:45 PM
- Form 1-A POS - • Edgar (US Regulatory) • 12/31/2025 12:32:47 PM
- Form 253G2 - • Edgar (US Regulatory) • 12/29/2025 08:29:49 PM
- Exousia Pro, Inc. Announces Executed LOI for Strategic Acquisition of High-Revenue Telehealth Platform to Accelerate Nutraceutical Commercialization • ACCESS Newswire • 12/11/2025 05:15:00 PM
- Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome(TM): The First All-Natural, Biologically Active Exosomal Supplement • ACCESS Newswire • 12/05/2025 04:00:00 PM
- Form 253G2 - • Edgar (US Regulatory) • 12/04/2025 09:35:28 PM
- Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms • ACCESS Newswire • 12/02/2025 06:45:00 PM
- Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy (LMMY) in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value • ACCESS Newswire • 11/17/2025 08:40:00 PM
- Exousia Pro Announces Breakthrough In Exosome-Based Delivery • ACCESS Newswire • 11/04/2025 03:40:00 PM
- Exousia Pro is Excited to Announce that it has Received Orphan Drug Designation from the FDA • ACCESS Newswire • 10/28/2025 02:20:00 PM
